BioSapien
Biosapien extends Pre-Series A round to $7 million
BioSapien, the pioneering biotech company behind MediChip, a revolutionary localized cancer treatment platform, has successfully extended its pre-Series A funding round to $7 million. This milestone i...
BioSapien raises $5.5mln in pre-series a funding led by Global Ventures
BioSapien, the patented drug delivery platform treating cancer ‘locally’, announces its $5.5 million (20.2M AED) pre-Series A fundraise. The funding was led by Global Ventures – MENA’s leading VC firm...